XNAS · ROIV
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Roivant Sciences Ltd. Common Shares

Roivant Sciences Ltd. Common Shares

PHARMACEUTICAL PREPARATIONS
$35.13
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is ROIV moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Roivant Sciences Ltd. Common Shares
PHARMACEUTICAL PREPARATIONS
Listed since
2021
Employees
721
Country
US

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$35.13
Last session
Day high
$35.13
Last session
Day low
$35.13
Last session
Previous close
$35.13
52W high
$35.13
0.00% from high
52W low
$35.13
Market cap
$25.3B
EPS
$-0.6500
Shares out
719.3M
VWAP
$35.13
Last session
Veridion warehouse edge

Warehouse intelligence for ROIV.

Veridion Score
Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ROIV insider activity

Roivant Sciences Ltd. Common Shares

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for ROIV.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ROIV contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ROIV in this window.
Lobbying spend

ROIV lobbying filings, year to date.

Registered lobbying filings matched to Roivant Sciences Ltd. Common Shares.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ROIV in this window.
Latest news · ROIV
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ROIV.
Options
Sovereign unlock shows live options positioning for ROIV.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.